Reviva Pharmaceuticals Holdings Inc.

11/06/2024 | Press release | Distributed by Public on 11/06/2024 07:06

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024 Earnings Release